Cardiff Oncology, Inc. insider trading

CRDFNASDAQ

$1.12-0.06 (-5.08%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-46.7%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

GWGary W. PaceDirector2.627%of company
JEJames E. LevineChief Financial Officer0.087%of company
MMMani MohindruChief Executive Officer0.0759%of company
BUBrigitte Ute LindsayChief Accounting Officer0.0353%of company
RPRenee P. TannenbaumDirector0.0257%of company
JBJoshua B. MuntnerChief Financial Officer0.0006%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
CRDF	Gary W. PaceDirector	Open market purchase$1M	+50.7%	$1.46	$1M	Jul 14, 2026	Jul 16, 2026
CRDF	Mani MohindruChief Executive Officer	Open market purchase$50K	+139.1%	$1.46	$50K	Jul 14, 2026	Jul 16, 2026
CRDF	Mani MohindruChief Executive Officer	Open market purchase$29.9K	Not reported	$1.21	$29.9K	Jun 18, 2026	Jun 22, 2026
CRDF	Gary W. PaceDirector	Open market purchase$36.6K	+2.3%	$1.22	$36.6K	Jun 18, 2026	Jun 22, 2026

End of history · 4 transactions